Radiation study for bone metastases with soft tissue mass
Part of Bones, joints & muscles, Cancer clinical trials.
This trial tests a new way of giving radiation (SFRT and SCART) to bone metastases that have a soft tissue mass. It may be an option if you have limited spread and your organs are working well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have a cancer that started in one place (not small cell or undifferentiated carcinoma) and has spread to a bone with a soft tissue mass at least 30 mm wide.
- You have not had radiation to that same bone metastasis before.
- You are able to take care of yourself (ECOG 0-2) and expected to live at least 3 months.
- Your blood counts and organ function (liver, kidneys, blood clotting) are within certain limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer way of giving radiation (spatially fractionated) compared to standard radiation for people with large soft tissue sarcomas. It aims to see if the new method works better.
This trial studies a type of focused radiation given in smaller parts to treat bone metastases from breast cancer. It may help shrink tumors and improve control of pain or growth when standard treatments haven’t worked or surgery isn’t possible.
This trial tests powerful, precisely aimed radiation (MR-guided stereotactic body radiation therapy) in a single session to treat 1 to 3 small metastatic tumors outside the brain and spine. It aims to control cancer growth with fewer visits and less impact on healthy tissue.
This study tests whether a focused, high-precision type of radiation can control many cancer spread-out spots (“metastases”) at the same time, while keeping side effects acceptable. It may help people with many metastases live longer or have better disease control by aiming treatment at every treatable spot.
This trial compares two types of radiation therapy—standard palliative radiation and a more targeted high-dose treatment (SBRT)—to see which better relieves pain from bone metastases that have spread outside the spine. It is for people with solid tumors who have a painful bone spot and are expected to live at least 6 months.
This trial tests a new type of radiation called spatially fractionated radiation therapy (SFRT) given before surgery for large soft tissue sarcomas in the arm, leg, or trunk. The goal is to see if it helps shrink the tumor and improve treatment outcomes.
Hear when a new Bone Metastases in Subjects With Advanced Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.